Cosmetics News and Research

RSS

New report proposes strategy to evaluate low-dose toxicity of endocrine disruptors

A new report by the National Academies of Sciences, Engineering, and Medicine proposes a strategy that the U.S. Environmental Protection Agency should use to evaluate the evidence of adverse human health effects from low doses of exposure to chemicals that can disrupt the endocrine system.

18 Jul 2017

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

18 Jul 2017

Scientists develop new method to accurately determine functional age of cells

Sure, you know how old you are, but what about your cells? Are they the same age? Are they older, younger? Why does it matter?

11 Jul 2017

New treatment receives FDA approval to reduce complications of sickle cell disease

The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

7 Jul 2017

Re-engineered Multi-IR box accessory for the Integrity 10 Reaction Station launched by Electrothermal

Cole-Parmer Ltd, a leading UK manufacturer of laboratory equipment, announced today that Electrothermal has launched the re-engineered Multi-IR box accessory for the Integrity 10 Reaction Station. The Multi-IR box accessory, originally developed in conjunction with Pfizer and the Illinois Institute of Technology, enables scientists across a broad range of global industries and laboratories to measure turbidity in-situ during experiments.

From Cole Parmer Limited 5 Jul 2017

FDA expands use of cooling cap to minimize chemotherapy-induced hair loss in cancer patients

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy.

3 Jul 2017

FDA authorizes marketing of test to aid in diagnoses of serious cancers

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

29 Jun 2017

FDA takes important steps to increase patient access to prescription drugs

Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives.

28 Jun 2017

Ingredient found in cosmetic cleaners can control wettability of the skin

It's possible to alter the wettability of your skin using an ingredient commonly found in cosmetic cleaners, according to new research from Binghamton University, State University of New York.

28 Jun 2017

Hidden dangers of personal care products and cosmetics revealed

According to a new study published yesterday in the Journal JAMA Internal Medicine, the problems related to the use of personal care products and cosmetics have nearly doubled in the last couple of years. Hair care products lead the race among the number of people unhappy with them. Two other problem areas include skin care products and tattoos.

26 Jun 2017

Flat head syndrome does not have consequences beyond cosmetics

The number of infants who develop flat head syndrome - deformational plagiocephaly – has increased significantly since the start of the Back to Sleep campaign to combat Sudden Infant Death Syndrome (SIDS) in the 1990s.

23 Jun 2017

Scientists urge caution on common antimicrobial chemicals Triclosan and Triclocarban

There are two ingredients, triclosan and triclocarban, that are used in several cleaning products such as soaps, toothpastes, detergents, carpets, paints etc. They are mainly used to kill the microbes such as bacteria, fungi and viruses. These chemicals however persist in the environment and continue to pose a risk says a new stud

20 Jun 2017

FDA approves expanded use of Sapien 3 THV as valve-in-valve treatment for high-risk patients

The U.S. Food and Drug Administration today approved an expanded indication for the Sapien 3 Transcatheter Heart Valve (THV) for patients with symptomatic heart disease due to failure of a previously placed bioprosthetic aortic or mitral valve whose risk of death or severe complications from repeat surgery is high or greater.

5 Jun 2017